Total Payments
$3,394
2024 Payments
$74.99
Companies
14
Transactions
50
Medicare Patients
1,900
Medicare Billing
$172,847
Payment Breakdown by Category
Travel$2,161 (63.7%)
Food & Beverage$1,061 (31.3%)
Education$171.89 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,161 | 5 | 63.7% |
| Food and Beverage | $1,061 | 42 | 31.3% |
| Education | $171.89 | 3 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $2,437 | 10 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $242.20 | 2 | $0 (2021) |
| Astellas Pharma US Inc | $186.76 | 3 | $0 (2024) |
| Novo Nordisk Inc | $174.50 | 11 | $0 (2022) |
| Currax Pharmaceuticals LLC | $67.66 | 5 | $0 (2021) |
| AbbVie Inc. | $58.29 | 3 | $0 (2021) |
| EISAI INC. | $54.37 | 4 | $0 (2019) |
| TherapeuticsMD, Inc. | $40.82 | 3 | $0 (2020) |
| Hologic, LLC | $32.74 | 2 | $0 (2018) |
| Coloplast Corp | $32.14 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.99 | 1 | Astellas Pharma US Inc ($74.99) |
| 2023 | $111.77 | 2 | Astellas Pharma US Inc ($111.77) |
| 2022 | $95.27 | 6 | Novo Nordisk Inc ($82.84) |
| 2021 | $347.15 | 9 | MERZ NORTH AMERICA, INC. ($242.20) |
| 2020 | $112.83 | 7 | Novo Nordisk Inc ($32.58) |
| 2019 | $121.63 | 9 | Coloplast Corp ($32.14) |
| 2018 | $38.30 | 3 | Novo Nordisk Inc ($14.96) |
| 2017 | $2,492 | 13 | BOSTON SCIENTIFIC CORPORATION ($2,437) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 06/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Biological | ||||||
| 01/10/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.00 | General |
| 11/29/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Obesity | ||||||
| 08/09/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Obesity | ||||||
| 04/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Obesity | ||||||
| 02/01/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.96 | General |
| 01/19/2022 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 01/18/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 11/16/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: WOMENS HEALTH | ||||||
| 09/15/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Obesity | ||||||
| 08/25/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: OBESITY | ||||||
| 06/30/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.77 | General |
| 06/23/2021 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $34.04 | General |
| 06/02/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: OBESITY | ||||||
| 04/15/2021 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $208.16 | General |
| 04/07/2021 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: WOMENS HEALTH | ||||||
| 01/21/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: OBESITY | ||||||
| 11/19/2020 | TherapeuticsMD, Inc. | IMVEXXY (Drug), ANNOVERA | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 11/05/2020 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: OBESITY | ||||||
| 10/08/2020 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: WOMENS HEALTH | ||||||
| 08/05/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Obesity | ||||||
| 07/23/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 02/20/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Obesity | ||||||
| 01/16/2020 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 484 | 763 | $99,552 | $47,069 |
| 2022 | 8 | 508 | 756 | $99,640 | $46,842 |
| 2021 | 8 | 473 | 672 | $84,619 | $43,809 |
| 2020 | 7 | 435 | 615 | $76,530 | $35,127 |
Total Patients
1,900
Total Services
2,806
Medicare Billing
$172,847
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 450 | $78,335 | $34,391 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $6,750 | $3,244 | 48.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 69 | 69 | $2,967 | $2,842 | 95.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 64 | 64 | $2,560 | $2,382 | 93.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 44 | $4,840 | $2,349 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,200 | $1,454 | 66.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 95 | 95 | $1,900 | $407.55 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 423 | $73,530 | $32,483 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 34 | $6,800 | $3,926 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $8,100 | $3,234 | 39.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 60 | 60 | $2,580 | $2,489 | 96.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 62 | 62 | $2,480 | $2,327 | 93.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 37 | $4,070 | $1,953 | 48.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 88 | 88 | $1,760 | $381.26 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 16 | $320.00 | $47.52 | 14.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 347 | $58,540 | $28,257 | 48.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $7,360 | $3,827 | 52.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 63 | $6,800 | $3,668 | 53.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 28 | $5,600 | $3,389 | 60.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 53 | 53 | $2,279 | $2,229 | 97.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 54 | 54 | $2,160 | $2,048 | 94.8% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 79 | 79 | $1,580 | $346.02 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 15 | 15 | $300.00 | $45.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 319 | $52,635 | $21,683 | 41.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 35 | 35 | $7,570 | $3,710 | 49.0% |
About Dr. Stefanie Mccain, M.D
Dr. Stefanie Mccain, M.D is a Obstetrics & Gynecology healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265539688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stefanie Mccain, M.D has received a total of $3,394 in payments from pharmaceutical and medical device companies, with $74.99 received in 2024. These payments were reported across 50 transactions from 14 companies. The most common payment nature is "Travel and Lodging" ($2,161).
As a Medicare-enrolled provider, Mccain has provided services to 1,900 Medicare beneficiaries, totaling 2,806 services with total Medicare billing of $172,847. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Abilene, TX
- Active Since 09/20/2006
- Last Updated 06/03/2016
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265539688
Products in Payments
- GENERAL - PELVIC ORGAN PROLAPSE (Device) $1,372
- SOLYX (Device) $793.87
- GREENLIGHT (Device) $265.15
- Saxenda (Drug) $112.70
- CONTRAVE (Drug) $109.51
- Belviq (Drug) $54.37
- LO LOESTRIN FE (Drug) $40.98
- ALTIS (Device) $32.14
- LILETTA (Drug) $30.52
- Veozah (Drug) $26.77
- IMVEXXY (Drug) $26.66
- Novasure Advanced (Device) $21.30
- Wegovy (Drug) $18.12
- ANNOVERA (Drug) $14.16
- Phexxi (Drug) $12.43
- Novasure (Device) $11.44
- SOLYX SIS SYSTEM (Device) $6.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Abilene
Erin Garner, D.o, D.O
Obstetrics & Gynecology — Payments: $51,538
Obstetrics & Gynecology $51,538
Dr. Timothy Hill, Md, MD
Obstetrics & Gynecology — Payments: $13,528
Obstetrics & Gynecology $13,528
Dr. Stuart Martin, M.d, M.D
Obstetrics & Gynecology — Payments: $10,325
Obstetrics & Gynecology $10,325
Megan Brown, M.d, M.D
Obstetrics & Gynecology — Payments: $2,315
Obstetrics & Gynecology $2,315
Kristen Mitchell
Obstetrics & Gynecology — Payments: $1,980
Obstetrics & Gynecology $1,980
Jacqueline Zimmerman, D.o, D.O
Obstetrics & Gynecology — Payments: $1,337
Obstetrics & Gynecology $1,337